Bausch + Lomb Unveils New Daily Astigmatism Lenses
Company Announcements

Bausch + Lomb Unveils New Daily Astigmatism Lenses

Bausch + Lomb Corporation (BLCO) has released an update.

Bausch + Lomb Corporation has launched INFUSE for Astigmatism, a new daily disposable contact lens for astigmatism sufferers in the U.S., featuring innovative ProBalance Technology™ and OpticAlign® design for all-day comfort and clear vision. The lenses offer unique properties such as high moisture content and breathability, and are designed to reduce common issues such as lens dryness and rotation. With promising initial study results and a wide range of in-office parameters, INFUSE for Astigmatism aims to meet the demand for performance and comfort in modern lifestyles.

For further insights into BLCO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBausch Health price target lowered to $7 from $8 at Truist
TheFlyBausch + Lomb price target raised to $20 from $18 at RBC Capital
TheFlyBausch + Lomb initiated with an Outperform at Raymond James
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!